We demonstrate that when using cell-laden core-shell
hydrogel beads to support the generation of
tumor spheroids, the shell structure reduces the out-of-bead and monolayer cell proliferation that occurs during long-term culture of
tumor cells within core-only
alginate beads. We fabricate core-shell beads in a two-step process using simple, one-layer
microfluidic devices.
Tumor cells encapsulated within the bead core will proliferate to form multicellular aggregates which can serve as three-dimensional (3-D) models of
tumors in
drug screening. Encapsulation in an
alginate shell increased the time that cells could be maintained in three-dimensional culture for MCF-7
breast cancer cells prior to out-of-bead proliferation, permitting formation of spheroids over a period of 14 days without the need move the cell-laden beads to clean culture flasks to separate beads from underlying monolayers.
Tamoxifen and
docetaxel dose response shows decreased toxicity for multicellular aggregates in three-dimensional core-shell bead culture compared to monolayer. Using simple core-only beads gives mixed monolayer and 3-D culture during
drug screening, and alters the treatment result compared to the 3-D core-shell or the 2-D monolayer groups, as measured by standard proliferation assay. By preventing the out-of-bead proliferation and subsequent monolayer formation that is observed with core-only beads, the core-shell structure can obviate the requirement to transfer the beads to a new culture flask during
drug screening, an important consideration for cell-based
drug screening and drugs which have high multicellular resistance index.